fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
cGMP deviations.
Official details
- Category
- Drug recall
- Status
- Ongoing
- Classification
- Class II
- Company or vendor
- Wells Pharma of Houston LLC
- Affected product
- U.S. Nationwide.
- Risk or reason
- cGMP deviations.
- Remedy or action
- Lot 020226202150202, Exp Date 05/05/2026.
- Official ID
- D-0508-2026